Fig. 1: LbGP inhibits proliferation, migration and invasion, and promotes apoptosis of glioma cells. | Cancer Gene Therapy

Fig. 1: LbGP inhibits proliferation, migration and invasion, and promotes apoptosis of glioma cells.

From: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c

Fig. 1

A Four kinds of glioma cells (U87, U251, GBM, LGG) were treated with LbGP at different concentrations, and cell viability was determined by CCK-8 assays. B Four kinds of glioma cells (U87, U251, GBM, LGG) were treated with 200 µg/ml LbGP for 24 h,48 h and 72 h, and cell viability was determined by CCK-8 assays. C–E Migration assays of the and GBM and U87 cells treated with 200 µg/ml LbGP for 24 h. F–G Transwell invasion assays of the GBM and U87 cells treated with 200 µg/ml LbGP for 24 h. H–I The apoptosis rates of the U87 cells and GBM cells treated with 200 µg/ml LbGP for 48 h were determined by flow cytometry. The data are presented as the mean ± SD of three replicates. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.

Back to article page